Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

RPR and Stanford enter research agreement for drug discovery and gene therapy

May 23, 1997

DepoMed seeks alliances for drug delivery systems

May 21, 1997

HemaSure stops development of SteriPath

May 20, 1997

LXR and Oxford Asymmetry enter drug discovery collaboration

May 14, 1997

Sugen researchers discover co-crystal of FGF TK

May 14, 1997

Avigen's gene therapy approach shows promise in preclinical studies

May 14, 1997

Cubist and Novalon collaborative research agreement

May 13, 1997

Titan receives U.S. patent for drug delivery to the CNS

May 13, 1997

Sonus and Valois collaborate on development of aerosol drug delivery system

May 12, 1997

Glaxo obtains license to technology and porphyrin compound for dermatological diseases

May 12, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...